{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:17:01Z","timestamp":1790835421701,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["DCS-NKI 2001\u20102423"],"award-info":[{"award-number":["DCS-NKI 2001\u20102423"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1093\/jnci\/djw329","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T12:05:35Z","timestamp":1481717135000},"source":"Crossref","is-referenced-by-count":70,"title":["Breast Cancer Survival of BRCA1\/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women"],"prefix":"10.1093","volume":"109","author":[{"given":"Marjanka K.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob A. E. M.","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T. H. B. M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Westenend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebl","family":"Brinkhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolter J. W.","family":"Oosterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryska L.","family":"Janssen-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Jobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"van \u2019t Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"issue":"23","key":"key\n\t\t\t\t20170810133946_djw329-B1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","year":"2015","journal-title":"N Engl J Med."},{"issue":"5","key":"key\n\t\t\t\t20170810133946_djw329-B2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ejhg.2014.161","article-title":"Evaluation of the Dutch BRCA1\/2 clinical genetic center referral criteria in an unselected early breast cancer population","volume":"23","year":"2015","journal-title":"Eur J Hum Genet."},{"issue":"4","key":"key\n\t\t\t\t20170810133946_djw329-B3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","year":"2015","journal-title":"J Clin Oncol."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different roles in a common pathway of genome protection","volume":"12","year":"2012","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-011-9213-5","article-title":"Inherited mutations in breast cancer genes\u2014risk and response","volume":"16","year":"2011","journal-title":"J Mammary Gland Biol Neoplasia."},{"issue":"11","key":"key\n\t\t\t\t20170810133946_djw329-B6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","year":"2004","journal-title":"Cancer Sci."},{"issue":"6","key":"key\n\t\t\t\t20170810133946_djw329-B7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1399-0004.1998.tb03764.x","article-title":"Inherited breast cancer: An emerging picture","volume":"54","year":"1998","journal-title":"Clin Genet."},{"issue":"4","key":"key\n\t\t\t\t20170810133946_djw329-B8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1014791115760","article-title":"The contribution of inherited factors to the clinicopathological features and behavior of breast cancer","volume":"6","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia."},{"issue":"21 suppl","key":"key\n\t\t\t\t20170810133946_djw329-B9","first-page":"113S","article-title":"Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer","volume":"18","year":"2000","journal-title":"J Clin Oncol."},{"issue":"11","key":"key\n\t\t\t\t20170810133946_djw329-B10","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1200\/JCO.1999.17.11.3653","article-title":"Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?","volume":"17","year":"1999","journal-title":"J Clin Oncol."},{"issue":"9127","key":"key\n\t\t\t\t20170810133946_djw329-B11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(05)79248-5","article-title":"Survival in early-onset BRCA1 breast-cancer patients","volume":"352","year":"1998","journal-title":"Lancet."},{"issue":"5","key":"key\n\t\t\t\t20170810133946_djw329-B12","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","year":"1998","journal-title":"J Clin Oncol."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B13","doi-asserted-by":"crossref","first-page":"e0120189","DOI":"10.1371\/journal.pone.0120189","article-title":"Worse breast cancer prognosis of BRCA1\/BRCA2 mutation carriers: What\u2019s the evidence? A systematic review with meta-analysis","volume":"10","year":"2015","journal-title":"PLoS One."},{"issue":"43","key":"key\n\t\t\t\t20170810133946_djw329-B14","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1038\/sj.onc.1209875","article-title":"Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations","volume":"25","year":"2006","journal-title":"Oncogene."},{"issue":"6","key":"key\n\t\t\t\t20170810133946_djw329-B15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1445-5994.2001.00075.x","article-title":"Current perspectives on BRCA1- and BRCA2-associated breast cancers","volume":"31","year":"2001","journal-title":"Intern Med J."},{"issue":"23","key":"key\n\t\t\t\t20170810133946_djw329-B16","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1200\/JCO.2008.19.9067","article-title":"Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"27","year":"2009","journal-title":"J Clin Oncol."},{"issue":"8","key":"key\n\t\t\t\t20170810133946_djw329-B17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jmg.39.8.608","article-title":"A significant response to neoadjuvant chemotherapy in BRCA1\/2 related breast cancer","volume":"39","year":"2002","journal-title":"J Med Genet."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","volume":"33","year":"2015","journal-title":"J Clin Oncol."},{"issue":"9","key":"key\n\t\t\t\t20170810133946_djw329-B19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: Estimates for sites other than breast and ovary","volume":"42","year":"2005","journal-title":"J Med Genet."},{"issue":"2","key":"key\n\t\t\t\t20170810133946_djw329-B20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","article-title":"Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations","volume":"51","year":"2014","journal-title":"J Med Genet."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.seminoncol.2009.03.001","article-title":"Breast cancer before age 40 years","volume":"36","year":"2009","journal-title":"Semin Oncol."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10552-007-9075-8","article-title":"On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975\u20132004: A long-term population-based study in southeastern Netherlands","volume":"19","year":"2008","journal-title":"Cancer Causes Control."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00439-011-1074-x","article-title":"Biobanking residual tissues","volume":"130","year":"2011","journal-title":"Hum Genet."},{"issue":"5","key":"key\n\t\t\t\t20170810133946_djw329-B24","first-page":"409","article-title":"Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1\/2 mutation carriers","volume":"34","year":"2015","journal-title":"J Clin Oncol."},{"issue":"13","key":"key\n\t\t\t\t20170810133946_djw329-B25","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.ejca.2009.03.008","article-title":"Regulatory aspects of genetic research with residual human tissue: Effective and efficient data coding","volume":"45","year":"2009","journal-title":"Eur J Cancer."},{"issue":"446","key":"key\n\t\t\t\t20170810133946_djw329-B26","first-page":"496","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","year":"1999","journal-title":"JAMA."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B27","article-title":"MICE: Multivariate imputation by chained equations in R","volume":"45","year":"2011","journal-title":"J Stat Software."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/EDE.0000000000000283","article-title":"Estimating excess hazard ratios and net survival when covariate data are missing: Strategies for multiple imputation","volume":"26","year":"2015","journal-title":"Epidemiology."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-014-2842-9","article-title":"Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1\/2 mutation status","volume":"144","year":"2014","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-014-2995-6","article-title":"Outcome of triple negative breast cancer: Comparison of sporadic and BRCA1-associated cancers","volume":"146","year":"2014","journal-title":"Breast Cancer Res Treat."},{"issue":"11","key":"key\n\t\t\t\t20170810133946_djw329-B31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE","volume":"105","year":"2013","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"key\n\t\t\t\t20170810133946_djw329-B32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canep.2010.07.001","article-title":"Characteristics and survival associated with ovarian cancer diagnosed as first cancer and ovarian cancer diagnosed subsequent to a previous cancer","volume":"35","year":"2011","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaoncol.2015.0658","article-title":"Effect of Oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"1","year":"2015","journal-title":"JAMA Oncol."},{"issue":"1","key":"key\n\t\t\t\t20170810133946_djw329-B34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-013-2425-1","article-title":"Time-trends in survival in young women with breast cancer in a SEER population-based study","volume":"138","year":"2013","journal-title":"Breast Cancer Res Treat."},{"issue":"9218","key":"key\n\t\t\t\t20170810133946_djw329-B35","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(00)02292-3","article-title":"Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?","volume":"355","year":"2000","journal-title":"Lancet."},{"issue":"9","key":"key\n\t\t\t\t20170810133946_djw329-B36","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","year":"2013","journal-title":"Ann Oncol."},{"key":"key\n\t\t\t\t20170810133946_djw329-B37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4236\/abcr.2015.44010","article-title":"Familial versus sporadic breast cancer: Different treatments for similar tumors?","volume":"4","year":"2015","journal-title":"Adv Breast Cancer Res."},{"issue":"25","key":"key\n\t\t\t\t20170810133946_djw329-B38","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2012.47.8313","article-title":"Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"31","year":"2013","journal-title":"J Clin Oncol."},{"issue":"3","key":"key\n\t\t\t\t20170810133946_djw329-B39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.29032","article-title":"Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis","volume":"136","year":"2015","journal-title":"Int J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170810133946_djw329-B40","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1245\/s10434-014-3930-0","article-title":"Survival analysis of contralateral prophylactic mastectomy: A question of selection bias","volume":"21","year":"2014","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"key\n\t\t\t\t20170810133946_djw329-B41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1200\/JCO.2015.62.0294","article-title":"Inferring the effects of cancer treatment: Divergent results from Early Breast Cancer Trialists\u2019 Collaborative Group meta-analyses of randomized trials and observational data from SEER registries","volume":"34","year":"2016","journal-title":"J Clin Oncol."},{"issue":"11","key":"key\n\t\t\t\t20170810133946_djw329-B42","doi-asserted-by":"crossref","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","article-title":"Breast cancer in young women: Poor survival despite intensive treatment","volume":"4","year":"2009","journal-title":"PLoS One."},{"issue":"7233","key":"key\n\t\t\t\t20170810133946_djw329-B43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancer: Population based study","volume":"320","year":"2000","journal-title":"BMJ."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/109\/8\/djw329\/19497403\/djw329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:21:29Z","timestamp":1718947289000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/doi\/10.1093\/jnci\/djw329\/3064570\/Breast-Cancer-Survival-of-BRCA1BRCA2-Mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,3,9]]},"published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djw329","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}